Treatment of oesophageal cancer

doi:10.1136/bmj.309.6947.125c

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Prognosis is not uniformly bad

Fayek Salama,
David Beggs,
Ellis Morgan

Consultant thoracic surgeon Associate specialist Consultant thoracic surgeon, City Hospital, Nottingham NG5 1PB.

EDITOR,—We agree with Seamus O'Reilly and Arlene Forastiere that surgery remains the standard treatment for resectable oesophageal cancer, but we do not agree that the outlook in such cases is almost hopeless.1 The review of Earlam and Cunha-Melo spanned two decades of all types of practice, and the latest paper in that review was published 16 years ago. This review is now of only historic interest and should not be quoted as a reflection of modern practice. Nor do we agree that most …